These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32646390)

  • 1. Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada.
    Fleming T; Valleriani J; Ng C; Maher L; Small W; McNeil R
    BMC Public Health; 2020 Jul; 20(1):1081. PubMed ID: 32646390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
    Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
    AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.
    Young AM; DiClemente RJ; Halgin DS; Sterk CE; Havens JR
    BMC Public Health; 2014 May; 14():537. PubMed ID: 24885970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis.
    Young AM; DiClemente RJ; Halgin DS; Sterk CE; Havens JR
    AIDS Behav; 2014 Sep; 18(9):1753-63. PubMed ID: 24849621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.
    Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S
    BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine acceptability and culturally appropriate dissemination among sexually diverse Aboriginal peoples in Canada.
    Newman PA; Woodford MR; Logie C
    Glob Public Health; 2012; 7(1):87-100. PubMed ID: 21390966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in HIV vaccine acceptability between genders.
    Kakinami L; Newman PA; Lee SJ; Duan N
    AIDS Care; 2008 May; 20(5):542-6. PubMed ID: 18484322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest in use of mHealth technology in HIV prevention and associated factors among high-risk drug users enrolled in methadone maintenance program.
    Shrestha R; Karki P; Copenhaver M
    AIDS Care; 2017 Sep; 29(9):1144-1148. PubMed ID: 28478706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Sisters, Mothers, Daughters and Aunties": HIV vaccine acceptability among African, Caribbean and other Black women in Toronto.
    Weaver J; Newman PA; Williams CC; Massaquoi N; Brown M
    Can J Public Health; 2013 Aug; 104(5):e413-7. PubMed ID: 24183184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES.
    Lee SJ; Newman PA; Duan N; Cunningham WE
    Vaccine; 2014 Sep; 32(39):5013-8. PubMed ID: 25045817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox?
    Dimi S; Zucman D; Chassany O; Lalanne C; Prazuck T; Mortier E; Majerholc C; Aubin-Auger I; Verger P; Duracinsky M
    BMC Infect Dis; 2019 May; 19(1):401. PubMed ID: 31072394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand.
    Newman PA; Roungprakhon S; Tepjan S; Yim S; Walisser R
    Glob Public Health; 2012; 7(9):1009-24. PubMed ID: 22780324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.
    Newman PA; Duan N; Lee SJ; Rudy ET; Seiden DS; Kakinami L; Cunningham WE
    Vaccine; 2006 Mar; 24(12):2094-101. PubMed ID: 16332402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study).
    Esparza J; Chang ML; Widdus R; Madrid Y; Walker N; Ghys PD
    Vaccine; 2003 May; 21(17-18):2032-41. PubMed ID: 12706693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining trends in exposures to harmful policing among people who inject drugs in Vancouver, Canada.
    Landsberg A; Kerr T; Milloy MJ; Dong H; Nguyen P; Wood E; Hayashi K
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20729. PubMed ID: 27435707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability, feasibility and challenges of implementing an HIV prevention intervention for people living with HIV/AIDS among healthcare providers in Mozambique: results of a qualitative study.
    Jaiantilal P; Gutin SA; Cummings B; Mbofana F; Rose CD
    SAHARA J; 2015; 12(1):2-9. PubMed ID: 25778860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Public Health Impacts of Private Security Guards on People Who Use Drugs: a Qualitative Study.
    Markwick N; McNeil R; Small W; Kerr T
    J Urban Health; 2015 Dec; 92(6):1117-30. PubMed ID: 26453195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.
    Shrestha R; Huedo-Medina TB; Altice FL; Krishnan A; Copenhaver M
    AIDS Behav; 2017 Nov; 21(11):3100-3110. PubMed ID: 28025735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of vaccination against HIV: A mapping of Togolese people's positions.
    Kpanake L; Gbandey S; Sorum PC; Mullet E
    J Health Psychol; 2018 May; 23(6):800-806. PubMed ID: 27611628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.